Consolidated Statements of Cash Flow - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income attributable to Ebix, Inc.	$ 93,847	$ 79,533	$ 63,558
Net income attributable to noncontrolling	447	0	0
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	10,746	10,634	9,681
Provision for doubtful accounts	1,515	3,111	1,600
Provision for deferred taxes, net of acquisitions and effects of currency translation	(6,410)	(10,143)	(1,966)
Unrealized foreign exchange (gain)/losses	32	(1,743)	(741)
Gain on investment interest in IHC/Ebix joint venture	(1,162)	0	0
Amortization of capitalized software development costs	1,116	0	0
Unrealized gain on put option	0	0	(296)
Share-based compensation	2,794	1,821	1,792
Debt discount amortization on convertible debt	0	17	35
Reduction of acquisition earn-out contingent liability	(1,344)	(1,533)	(10,237)
Changes in current assets and liabilities, net of acquisitions:
Accounts receivable	(12,659)	(7,320)	(1,530)
Other assets	(1,034)	(3,834)	(4,765)
Accounts payable and accrued expenses	(3,703)	(19,895)	14,670
Accrued payroll and related benefits	170	(60)	1,811
Deferred rent	(234)	(656)	(324)
Reserve for potential uncertain income tax return positions	490	95	(9,723)
Liability – securities litigation settlement	0	(690)	(3,528)
Other liabilities	(3,039)	1,111	(221)
Deferred revenue	2,176	(1,762)	(1,306)
Net cash provided by operating activities	83,748	48,686	58,510
Cash flows from investing activities:
Investment in Ebix Health Solutions, LLC Joint Venture, net of cash acquired	(696)	(6,000)	0
Purchases of marketable securities	(2,115)	(1,435)	0
Maturities of marketable securities	0	0	495
Capitalized software development costs	(3,988)	(3,489)	0
Capital expenditures	(5,977)	(13,994)	(16,277)
Net cash used in investing activities	(20,739)	(37,393)	(77,786)
Cash flows from financing activities:
Proceeds from / (Repayment) to line of credit, net	(52,436)	86,000	97,625
Proceeds from term loan	125,000	0	0
Principal payments on term loan obligation	(6,250)	(642)	(31,938)
Repurchase of common stock	(59,784)	(81,653)	(31,854)
Payments of long term debt	(600)	0	(345)
Payments for capital lease obligations	(5)	(10)	(231)
Excess tax benefit from share-based compensation	0	463	(3,200)
Proceeds from exercise of common stock options	824	2,209	788
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(998)	(2,202)	(41)
Shares reacquired in connection with put option	0	0	(3,535)
Dividends paid	(9,829)	(10,472)	(11,406)
Net cash provided (used) by financing activities	(4,078)	(6,307)	15,863
Effect of foreign exchange rates on cash and cash equivalents	(1,992)	(107)	(961)
Net change in cash and cash equivalents	56,939	4,879	(4,374)
Cash and cash equivalents at the beginning of the year	57,179	52,300	56,674
Cash and cash equivalents at the end of the year	114,118	57,179	52,300
Supplemental disclosures of cash flow information:
Interest paid	7,219	5,379	1,290
Income taxes paid	16,634	28,637	11,433
IHAC(Hope)
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	(1,643)	0	0
WDEV
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	(6,320)	0	0
Via Media Health
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	(1,000)	0
PB Systems
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	(11,475)	0
Curepet, Inc.
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	3
ADAM
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	(5,856)
Vertex
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	(27,547)
Oakstone
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	(23,791)
I3
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	(2,000)
Taimma
Cash flows from investing activities:
Payments of acquisition earn-out contingencies	0	0	(2,250)
TriSystems
Cash flows from investing activities:
Payments of acquisition earn-out contingencies	$ 0	$ 0	$ (563)